Skip to content
Clinical Trials – home
Therapeutic area

Injury, poisoning and procedural complications – page 13

  • 286 clinical trials
  • 125 recruiting
  • 217 conditions
  • 25 countries

Conditions in this area

217 conditions with trials, the busiest first

Clinical trials in Injury, poisoning and procedural complications

286 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

286 clinical trials

Skin wound

Not yet recruiting

Safety, tolerability and efficacy of topical human fibroblasts in patients with chronic refractory wounds (two-part study)

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:HUMAN FIBROBLASTS

Graft versus host disease

Not yet recruiting

Study of Mesenchymal Stromal Cells expressing CXCR4 and IL-10 for patients with acute Graft Versus Host Disease who do not respond to steroids or ruxolitinib

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:ALLOGENEIC ADIPOCYTE-DERIVED MESENCHYMAL STROMAL CELLS TRANSDUCED WITH A LENTIVIRAL PROVIRUS VECTOR CONTAINING THE HUMAN CXCR4 AND IL-10 GENES
  • Sponsor:Fundacion Instituto De Investigacion Sanitaria De Navarra

Post concussion syndrome

Not yet recruiting

Study of dexamethasone for the treatment of brain bruising and swelling in patients with traumatic brain injury

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:University Hospital Son Espases

Post procedural complication+3

Not yet recruiting

Study of lidocaine hydrochloride to reduce side effects from pain medication in patients undergoing open liver surgery

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Centre Hospitalier Universitaire De Rennes

Wound infection pseudomonas

Not yet recruiting

Safety and efficacy of elfucose, d‑galactose and polyhexanide solution 20% in patients with chronic wounds colonized by Pseudomonas aeruginosa

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:PathoBlock Therapeutics GmbH & Co. KG

Hypoparathyroidism

Not yet recruiting

A study to evaluate the safety and effects of palopegteriparatide in adolescents with chronic hypoparathyroidism

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years
  • Substances:Palopegteriparatide
  • Sponsor:Ascendis Pharma Bone Diseases A/S

Skin wound

Not yet recruiting

Testing Bacteriophage Cocktail Safety and Effectiveness in Patients with Complicated Infected Wounds Compared to Placebo

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:MB PHARMA s.r.o.

Chemical burn

Not yet recruiting

Treatment of Severe Eye Chemical Burns with Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells for Patients with Severe Ocular Chemical Burns

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Fondation A De Rothschild

Craniocerebral injury

Not yet recruiting

A Study Testing Propranolol for Patients with Traumatic Brain Injury Who Need Intensive Care Unit Treatment

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Propranolol Hydrochloride
  • Sponsor:University Hospital Son Espases

Procedural pain+1

Not yet recruiting

Comparing Low and Intermediate Doses of Dexamethasone for Rebound Pain After Foot Surgery in Patients Receiving Nerve Block Anesthesia

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone Sodium Phosphate
  • Sponsor:Hospital Universitario Dr Peset Aleixandre

Procedural pain

Not yet recruiting

Comparing tramadol and morphine for pain relief after laparoscopic abdominal surgery in adults

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Morphine Sulfate
  • Sponsor:Centre Hospitalier Universitaire Amiens Picardie

Toxic epidermal necrolysis

Not yet recruiting

Study of Tildrakizumab for Eye Problems in Patients with Lyell Syndrome

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Tildrakizumab
  • Sponsor:TOXILYON

Substances studied in this area

The therapies tested most often in Injury, poisoning and procedural complications trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.